This call is launched in partnership with the FRS_FNRS - To apply please click on http://www.generetaward.be
Rare diseases are life threatening or chronic conditions which affect no more than 1 person out of 2.000. Currently many patients are not diagnosed or do not benefit from an appropriate treatment. Scientific research is crucial to improve the quality of life of the patients. By launching an annual call for projects, the Fund Generet wants to support research on rare diseases with the aim to better understand the processes (causes and mechanisms) underpinning rare diseases and/or to turn fundamental discoveries into better prevention, diagnosis or treatment of patients.
The call is aimed to two categories of researchers: confirmed researchers in rare diseases and confirmed researchers with a track record in more common pathologies who can demonstrate that their research will have a substantial added value for rare diseases and can accelerate research in this particular field.
International and interdisciplinary collaboration are strongly encouraged.
The annual Generet Award of 1.000.000 € for 1 single project aims to catalyse the research agenda on rare diseases in Belgium and beyond. The amount will be paid in 2 phases of 500.000 euros. The second support is conditional to a positive midterm review. Part of the budget may be outsourced for supporting international expenses.
High level, internationally established researchers working in Belgium, with outstanding scientific achievements in rare diseases or willing to develop a research line in rare diseases.
Applications are open to established researchers inrare diseases.
Eligible Countries:
Sponsor Institute/Organizations: Koning Boudewijnstichting
Sponsor Type: Corporate/Non-Profit
Address: Rue Brederode 21 1000 Brussels
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
May 12, 2025
Aug 11, 2025
$1,135,535
Affiliation: Koning Boudewijnstichting
Address: Rue Brederode 21 1000 Brussels
Website URL: https://kbs-frb.be/en/generet-fund-6
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.